Morgan H. James

Affiliations: 
Anatomy The University of Newcastle 
Area:
Addiction Neurobiology , VTA, Hypothalamus
Google:
"Morgan James"
Mean distance: 16.83 (cluster 19)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fragale JE, James MH, Aston-Jones G. (2020) Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system. Addiction Biology. e12946
Freeman LR, Bentzley BS, James MH, et al. (2020) Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System. The International Journal of Neuropsychopharmacology
James MH, Fragale JE, Aurora RN, et al. (2020) Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
James MH, Aston-Jones G. (2020) Introduction to the Special Issue: "Orexin/hypocretin receptor antagonists for the treatment of addiction and related psychiatric disease: What are the steps from here?" Brain Research. 146665
Mohammadkhani A, Fragale JE, Pantazis CB, et al. (2019) Orexin-1 receptor signaling in ventral pallidum regulates motivation for the opioid remifentanil. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Mohammadkhani A, James MH, Pantazis CB, et al. (2019) Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil. Brain Research. 146461
Pantazis CB, James MH, Bentzley BS, et al. (2019) The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand. Addiction Biology. e12795
Fragale JE, Pantazis CB, James MH, et al. (2019) The role of orexin-1 receptor signaling in demand for the opioid fentanyl. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Wiskerke J, James MH, Aston-Jones G. (2019) The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task. Brain Research
Yeoh JW, James MH, Adams CD, et al. (2018) Activation of lateral hypothalamic group III mGluRs suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells. Neuropharmacology
See more...